Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment

Relugolix as a promising novel oral GnRH antagonist for prostate cancer treatment

Bibliographic Details
Main Authors:	Jialu Lv, Jianqing Lin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Asian Journal of Andrology
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2021;volume=23;issue=3;spage=229;epage=230;aulast=Lv

Similar Items

Exploring the impact of GnRH agonist and GnRH antagonist on the risk of atopic diseases in patients with prostatic cancer
by: Mei-Yu Lee, et al.
Published: (2018)

Comparison of GnRH Agonist, GnRH Antagonist, and GnRH Antagonist Mild Protocol of Controlled Ovarian Hyperstimulation in Good Prognosis Patients
by: Martin Stimpfel, et al.
Published: (2015-01-01)

Relugolix, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist, in women with endometriosis-associated pain: phase 2 safety and efficacy 24-week results
by: Yutaka Osuga, et al.
Published: (2021-06-01)

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology
by: Cota Ana Marcia M, et al.
Published: (2012-04-01)

GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors
by: Samantha Sperduti, et al.
Published: (2019-11-01)

GnRH agonist versus GnRH antagonist in <it>in vitro</it> fertilization and embryo transfer (IVF/ET)
by: Depalo Raffaella, et al.
Published: (2012-04-01)

A Flexible Multidose GnRH Antagonist versus a Microdose Flare-Up GnRH Agonist Combined with a Flexible Multidose GnRH Antagonist Protocol in Poor Responders to IVF
by: Gayem İnayet Turgay Çelik, et al.
Published: (2015-01-01)

Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
by: Maryam Eftekhar, et al.
Published: (2013-01-01)

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols
by: Hwu Yuh-Ming, et al.
Published: (2009-03-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

Studies on ovarian GnRH-R and GnRH mRNA, and the direct effects of GnRH on ovarian function in the bovine
by: Ramakrishnappa, Nagaraja
Published: (2009)

A prospective study of GnRH long agonist versus flexible GnRH antagonist protocol in PCOS: Indian experience
by: Harpreet Kaur, et al.
Published: (2012-01-01)

GnRH Antagonist/Letrozole Versus Microdose GnRH Agonist Flare Protocol in Poor Responders Undergoing In Vitro Fertilization
by: Robab Davar, et al.
Published: (2010-09-01)

Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study
by: Abbas Aflatoonian, et al.
Published: (2017-08-01)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
by: Rahul Jena
Published: (2020-01-01)

Gonadotropin-Releasing Hormone (GnRH) Receptor Structure and GnRH Binding
by: Colleen A. Flanagan, et al.
Published: (2017-10-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

A cumulative strategy of GnRH agonist, clomiphene citrate, and GnRH antagonist in a patient with recurrent endometriosis and repeated aspiration
by: Su-Long Lee, et al.
Published: (2011-09-01)

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article
by: Ashraf Alyasin, et al.
Published: (2016-09-01)

Melatonin Inhibits GnRH-1, GnRH-3 and GnRH Receptor Expression in the Brain of the European Sea Bass, Dicentrarchus labrax
by: José Antonio Muñoz-Cueto, et al.
Published: (2013-04-01)

A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
by: Rumiko Sugimura, et al.
Published: (2019-09-01)

Flexible Multi-dose GnRH Antagonist versus Long GnRH Agonist Protocol in Poor Responders: A Randomized Controlled Trial
by: Ensieh Shahrokh Tehraninejad, et al.
Published: (2009-02-01)

Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.
by: Rok Devjak, et al.
Published: (2012-01-01)

A Novel Nomogram for Individualized Gonadotropin Starting Dose in GnRH Antagonist Protocol
by: Yubin Li, et al.
Published: (2021-09-01)

Androgen deprivation therapy and side effects: are GnRH antagonists safer?
by: Stephen J Freedland, et al.
Published: (2021-01-01)

Oxidative stress markers in GnRH agonist and antagonist protocols in IVF
by: Tulić Lidija, et al.
Published: (2017-01-01)

The GnRH Pulse Generator
by: Pasha Grachev, et al.
Published: (2016-12-01)

A Biological role for GnRH I and GnRH II at the maternal-fetal interface
by: Zhou, Junshan
Published: (2009)

Transciptional regulation of human gonadotropin-releasing hormone (GnRH) and GnRH receptor genes
by: Cheng, Chi Keung
Published: (2009)

A Biological role for GnRH I and GnRH II at the maternal-fetal interface
by: Zhou, Junshan
Published: (2009)

Novel Crizotinib–GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems
by: József Murányi, et al.
Published: (2019-11-01)

GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.
by: Ming-Chao Huang, et al.
Published: (2018-01-01)

Low-dose GnRH antagonist protocol is as effective as the long GnRH agonist protocol in unselected patients undergoing in vitro fertilization and embryo transfer
by: Shang-Yu Huang, et al.
Published: (2011-12-01)

Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients
by: Jiann-Loung Hwang, et al.
Published: (2018-06-01)

Differential roles of GnRH-I and GnRH-II neurons in the control of the primate reproductive axis
by: Henryk eUrbanski
Published: (2012-02-01)

Stop GnRH-Agonist Combined With Multiple-Dose GnRH-Antagonist Protocol for Patients With “Genuine” Poor Response Undergoing Controlled Ovarian Hyperstimulation for IVF
by: Raoul Orvieto, et al.
Published: (2020-05-01)

Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis.
by: Jin-song Xiao, et al.
Published: (2014-01-01)

Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis.
by: Ruolin Wang, et al.
Published: (2017-01-01)

GnRH antagonist for pituitary supression in IVF: Is it time for a change of practice?
by: Amr Wahba, et al.
Published: (2011-12-01)

Return to fertility after extended chemical castration with a GnRH antagonist
by: Schrier Bruce, et al.
Published: (2001-10-01)

Cannot write session to /tmp/vufind_sessions/sess_issjbqug8eicvikcfiobebggph